title: Selective aggregation of endogenous beta-amyloid peptide and soluble amyloid precursor protein in cerebrospinal fluid by zinc.
abstract: Zinc added to buffered solutions of synthetic beta-amyloid peptide (A beta) has been reported to induce accelerated formation of insoluble aggregates. This observation suggests that zinc may play a role in the formation of senile plaques, which contain A beta, in Alzheimer's disease. To test this hypothesis under conditions more representative of the brain, we investigated the ability of zinc to induce aggregation of A beta in freshly drawn canine CSF, which contains the same sequence as human A beta. Aggregates were separated from CSF by ultracentrifugation before and after incubation with zinc and assayed by quantitative western blotting and ELISA. We found that zinc induced the rapid aggregation of endogenous A beta in CSF, with an EC50 of 120-140 microM. The reaction was specific, because most (> or = 95%) CSF protein remained soluble under conditions where most A beta was insoluble, as assayed by scanning densitometry of Coomassie-stained gels. Staining of the precipitated material resulted in the visualization of punctate regions that were thioflavin positive or birefringent when stained with Congo red, suggesting the formation of amyloid-related structures. These results suggest that zinc could play a role in amyloid deposition, because there is overlap between the regions of the brain where zinc concentrations are highest and regions with the highest amyloid content. It is surprising that zinc induced the aggregation of endogenous soluble APP at lower concentrations than required for A beta (EC50 80 microM). The possibility that zinc-induced aggregation of APP may precede the deposition of A beta into plaques is discussed. Investigation of aggregation of A beta in CSF will aid in assessing the biological relevance of other agents that have been reported to accelerate amyloid formation.
authors.affiliation: Department of CNS Disorders, Wyeth-Ayerst Research, Princeton, New Jersey, U.S.A.
authors.forename: A M
authors.initials: AM
authors.lastname: Brown
authors.forename: D M
authors.initials: DM
authors.lastname: Tummolo
authors.forename: K J
authors.initials: KJ
authors.lastname: Rhodes
authors.forename: J R
authors.initials: JR
authors.lastname: Hofmann
authors.forename: J S
authors.initials: JS
authors.lastname: Jacobsen
authors.forename: J
authors.initials: J
authors.lastname: Sonnenberg-Reines
mesh_terms: D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid* / Q000737:chemistry / Q000187:drug effects; D016564:Amyloid beta-Protein Precursor / Q000134:cerebrospinal fluid* / Q000737:chemistry / Q000187:drug effects; D000818:Animals; D052160:Benzothiazoles; D015153:Blotting, Western; D003224:Congo Red; D004285:Dogs; D004797:Enzyme-Linked Immunosorbent Assay; D005456:Fluorescent Dyes; D006801:Humans; D013844:Thiazoles; D015032:Zinc / Q000494:pharmacology*
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D052160:Benzothiazoles; D005456:Fluorescent Dyes; D013844:Thiazoles; C009462:thioflavin T; D003224:Congo Red; D015032:Zinc